Newtonville, MA, United States of America

Billy W Day


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Billy W. Day

Introduction

Billy W. Day is an accomplished inventor based in Newtonville, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiestrogens and antitumor agents. His work has the potential to impact cancer treatment and hormone-related therapies.

Latest Patents

Billy W. Day holds a patent for "Triarylcyclopropanes as antiestrogens and antitumor agents." This patent describes triarylcyclopropane derivatives, where one or more of the aryl groups includes a hydroxy as a substituted or unsubstituted or alkoxy or side chain substituent. The compounds developed through this research are useful as antiestrogens and anti-tumor agents, showcasing his innovative approach to addressing critical health issues.

Career Highlights

Billy W. Day is affiliated with the University of Oklahoma, where he continues to advance his research in medicinal chemistry. His work has garnered attention for its potential applications in treating various forms of cancer. With a focus on developing effective therapeutic agents, he has established himself as a key figure in his field.

Collaborations

Billy W. Day has collaborated with notable colleagues, including Robert A. Magarian and Joseph T. Pento. These partnerships have contributed to the advancement of his research and the successful development of innovative compounds.

Conclusion

Billy W. Day's contributions to the field of pharmaceuticals through his patent and research at the University of Oklahoma highlight his dedication to innovation in cancer treatment. His work exemplifies the importance of collaboration and creativity in scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…